|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
CEA, Pancreatic Cyst Fluid
Test CodeCEAPCF
Preferred Specimen
1 mL pancreatic cyst fluid
Minimum Volume
0.5 mL
Transport Container
Plastic vial
Transport Temperature
Refrigerated
Specimen Stability
7 days refrigerated
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis
Report Available
2-4 days
Reference Range
An interpretive report will be provided.
Clinical Significance
The diagnosis of pancreatic cyst type is often difficult and may require correlating imaging studies with results of cytologic examination and tumor marker testing performed on cyst aspirates. Various tumor markers have been evaluated to distinguish nonmucinous, nonmalignant pancreatic cysts from mucinous cysts, which have a high likelihood of malignancy. Carcinoembryonic antigen (CEA) has been found to be the most reliable tumor marker for identifying those pancreatic cysts that are likely mucinous. In cyst aspirates, CEA concentrations > or =200 ng/mL are highly suspicious for mucinous cysts. The greater the CEA concentration, the greater the likelihood that the mucinous cyst is malignant. However, CEA testing does not reliably distinguish between benign, premalignant, or malignant mucinous cysts. CEA test results should be correlated with the results of imaging studies, cytology, other cyst fluid tumor markers (ie, amylase and CA 19-9), and clinical findings for diagnosis.